Systemic medical therapy of melanoma
When is this procedure indicated?
It is indicated in patients with metastatic melanoma and/or in patients who have a high risk of developing metastases after removal of the primary tumor.
How is it performed?
The target therapy is administered by means of tablets that the patient can easily take at home, while the immunotherapy is administered intravenously.